实用药物与临床2025,Vol.28Issue(1) :57-61.DOI:10.14053/j.cnki.ppcr.202501011

阿托伐他汀联用加巴喷丁致横纹肌溶解症1例及药物警戒分析

Rhabdomyolysis induced by combination of atorvastatin and gabapentin:a case re-port and disproportionate analysis

王丽虹 陈设 魏小娟 张杰
实用药物与临床2025,Vol.28Issue(1) :57-61.DOI:10.14053/j.cnki.ppcr.202501011

阿托伐他汀联用加巴喷丁致横纹肌溶解症1例及药物警戒分析

Rhabdomyolysis induced by combination of atorvastatin and gabapentin:a case re-port and disproportionate analysis

王丽虹 1陈设 2魏小娟 1张杰2
扫码查看

作者信息

  • 1. 福州市第二总医院,福建 福州 350007
  • 2. 广东省中医院,广东 广州 510000
  • 折叠

摘要

目的 探讨阿托伐他汀与加巴喷丁联用导致横纹肌溶解症的临床特点.方法 1例患者服用阿托伐他汀并间断联用加巴喷丁后出现横纹肌溶解症.通过检索FAERS数据库,分析横纹肌溶解症与阿托伐他汀和/或加巴喷丁的关联性.结果 以阿托伐他汀为首要怀疑药品的不良事件信号强于加巴喷丁;阿托伐他汀联用加巴喷丁的不良事件信号强于非联用.通过回顾本例患者用药史及病程,考虑二者联用致横纹肌溶解可能性大.结论 阿托伐他汀与加巴喷丁联用可致横纹肌溶解的严重罕见不良反应,尤其合并感染、肾功能不全时.二者联用应注意患者的肾功能指标,并避免长时间联用.

Abstract

Objective To explore the clinical characteristics of rhabdomyolysis caused by the combination of atorvastatin and gabapentin.Methods A case of rhabdomyolysis after intermittent combination of atorvastatin and ga-bapentin was reported,and a disproportionate analysis was conducted on the FAERS database to explore the correlation between rhabdomyolysis and atorvastatin and/or gabapentin.Results The signal of adverse events mainly suspected to be caused by atorvastatin was stronger than that of gabapentin.In the adverse event signals caused by atorvastatin combined with gabapentin was stronger than non-accompanied events.By reviewing the medication history and disease course of this patient,it was considered that the combination of the two drugs was likely to cause rhabdomyolysis.Con-clusion When atorvastatin and gabapentin are used in combination,they can cause serious and rare adverse reactions of rhabdomyolysis,especially when complicated with infections and renal insufficiency.When combination use of the two drugs,attention should be paid to the patient's renal function indicators and avoid prolonged use.

关键词

阿托伐他汀/加巴喷丁/横纹肌溶解/FAERS数据库

Key words

Atorvastatin/Gabapentin/Rhabdomyolysis/FAERS

引用本文复制引用

出版年

2025
实用药物与临床
辽宁省药学会,中国医科大学附属盛京医院

实用药物与临床

CSTPCD
影响因子:1.633
ISSN:1673-0070
段落导航相关论文